|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 28, 2018 05:57PM
|
|
Re: BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 01, 2018 11:38AM
|
|
Re: Blood test coming for Earlier Detection of Alzheimer's
|
5
|
Resverlogix Corp.
|
Mar 05, 2018 10:54PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 05, 2018 11:08PM
|
|
March Madness?
|
4
|
Resverlogix Corp.
|
Mar 06, 2018 08:53AM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 10:13AM
|
|
Re: Statistical Considerations
|
10
|
Resverlogix Corp.
|
Mar 06, 2018 02:22PM
|
|
Re: Statistical Considerations
|
6
|
Resverlogix Corp.
|
Mar 06, 2018 03:06PM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 07, 2018 12:55PM
|
|
Re: Statistical Considerations
|
5
|
Resverlogix Corp.
|
Mar 07, 2018 06:20PM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 07, 2018 11:17PM
|
|
Re: Statistical Considerations
|
6
|
Resverlogix Corp.
|
Mar 08, 2018 11:07PM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 09, 2018 09:57AM
|
|
Re: Statistical Considerations
|
2
|
Resverlogix Corp.
|
Mar 09, 2018 10:05AM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 09, 2018 11:14AM
|
|
Re: Statistical Considerations
|
3
|
Resverlogix Corp.
|
Mar 09, 2018 11:58AM
|
|
Re: 188 Mace events?
|
9
|
Resverlogix Corp.
|
Mar 10, 2018 02:34PM
|
|
ODYSSEY and Anti-histamines
|
7
|
Resverlogix Corp.
|
Mar 11, 2018 10:33AM
|
|
Re: Zenith and Breast Cancer
|
2
|
Zenith Epigenetics
|
Mar 11, 2018 10:47AM
|
|
Re: Marching on to March events
|
4
|
Zenith Epigenetics
|
Mar 12, 2018 12:15PM
|
